Skip to content
★ Sign in to follow
MC

Margie Chassman

Stem Cell Innovations, Inc.Cytosorbents CorpNiagen Bioscience, Inc.
Total declarations
10
Companies
3
▲ Purchases (1 ops.)
€1,659
▼ Sales (1 ops.)
—

Latest filing published 17 Jul 2008 for Niagen Bioscience, Inc., €1,659.

Insider track record

Disclosed buys
1
Disclosed sells
1
Signal history

No signal scores available.

Closed purchases

Market purchases
1

Not enough history yet: 1 closed purchase, at least 2 are needed.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Margie Chassman: trading record in brief

Margie Chassman is a declared insider at 3 companies; the most frequent names are Stem Cell Innovations, Inc., Cytosorbents Corp and Niagen Bioscience, Inc. The record holds 10 filings, for trades running from 25 May 2005 to 16 July 2008.

The open-market side counts 1 purchase for €1,659 alongside 1 sale. The totals do not cover 1 filing with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. 2008 to date brings 1 purchase and no sales.

Most recently, on 17 July 2008, the filings show an open-market purchase worth €1,659 in Niagen Bioscience, Inc. Filings reach the SEC (Form 4) feed a median of 30 days after the trade. For comparison, the SEC allows two business days to file a Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Margie Chassman

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations10 total

10 of 10 declarations